Related Experiment Videos
Coenzyme alterations in rats with experimental hypertension.
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie
|February 27, 1976
Summary
Hypertension alters pyridine nucleotide coenzymes (NAD+ and NADH) differently across models. Salt-induced hypertension increases coenzymes in kidneys and vessels, while other models show varied effects, highlighting distinct biochemical pathways in hypertension.
Area of Science:
- Biochemistry
- Cardiovascular Research
- Metabolic Studies
Background:
- Pyridine nucleotide coenzymes, NAD+ and NADH, are crucial for cellular metabolism.
- Altered coenzyme levels are implicated in various disease states, including hypertension.
- Understanding these changes in different hypertension models is key to elucidating disease mechanisms.
Purpose of the Study:
- To investigate the impact of diverse experimental hypertension models on NAD+ and NADH coenzyme levels.
- To compare the specific changes in coenzyme content across the kidneys, liver, and vessel walls in each hypertension model.
- To assess the effect of prostaglandin E1 treatment on coenzyme levels in adrenal-regeneration hypertension.
Main Methods:
- Studied pyridine nucleotide coenzyme (NAD+ and NADH) content.
- Utilized four distinct models of experimentally induced hypertension: genetic spontaneous hypertension (SHR), one-kidney Goldblatt hypertension, adrenal-regeneration hypertension (ARH), and NaCl hypertension.
- Administered prostaglandin E1 to ARH models to observe its effect on coenzyme levels.
Main Results:
- NaCl hypertension showed elevated coenzymes in kidneys and vessel walls, with normal liver levels.
- Adrenal-regeneration hypertension exhibited increased coenzymes in kidneys, liver, and vessel walls; prostaglandin E1 normalized these levels.
- Renal hypertension presented decreased NAD+, increased NADH, and a lower NAD+/NADH ratio in kidneys and liver, with moderate vessel wall increases.
- Spontaneous hypertensive rats (SHR) displayed kidney coenzyme changes similar to renal hypertension but lower vessel wall coenzyme levels compared to other models.
Conclusions:
- Hypertension models exhibit distinct patterns of pyridine nucleotide coenzyme alterations in key organs and tissues.
- These findings suggest that different hypertension etiologies involve unique metabolic dysregulations.
- Targeting coenzyme balance may offer therapeutic potential, as suggested by prostaglandin E1's effect in ARH.